Sign in
4

Changes in Ownership

ADC Therapeutics SA Filed Acc 0001628280-25-005859

Chief Executive Officer acquired 650,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MALLIK AMEET Chief Executive Officer 2025-02-13 Grant or award +650,000 $1.61 $1,046,500 1,579,005 D
Loading xslF345X05/wk-form4_1739575251.xml…